Morning Overview on MSN
Weight-loss drugs delivered big results but left doctors with big unanswered questions
Semaglutide and tirzepatide have produced some of the largest weight reductions ever recorded in clinical trials, with losses ...
Morning Overview on MSN
Ozempic helped adults over 65 shed more than 15% of their body weight in a new study
Adults aged 65 and older who took semaglutide 2.4 mg lost an average of 15.4% of their body weight over 68 weeks, according ...
What if your biggest challenges could become your greatest teachers? Learn five ACT-based ways to work with problems instead ...
Many students appear to be completing assignments faster while learning less from them. This conclusion comes from one of the largest studies of how generative AI is changing student behavior and ...
Polypharmacy in patients with cardiovascular disease occurs frequently across the age spectrum and can lead to inappropriate ...
Older patients represent the fastest growing patient group in clinical care. They are a heterogeneous group, for whom evidence for making treatment decisions is often scarce. Important domains for ...
GLP-1 microdosing is when people take smaller doses of GLP-1 drugs than are typically prescribed or FDA-recommended, often ...
Pangea Pharmaceuticals, a U.S.-based, patient-centered pharmaceutical company focused on bringing differentiated, clinically relevant products to market, today announced the next phase of its growth ...
So you’ve connected a device to your PC via a USB port — but Windows doesn’t recognize it. What now? Before you assume the product (or your PC port) is broken, there are several USB troubleshooting ...
Men may be more likely to experience certain health conditions, including prostate cancer, erectile dysfunction, heart disease, lung cancer, depression, and alcohol use disorder. Early screening for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results